NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20480 | ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate | 2359650-50-1 | ≧96.0% |  |
| 230401 | Glycerol phenylbutyrate ( HPN-100 ) | 611168-24-2 | ≧98.0% |  |
| Glycerol phenylbutyrate, also known as HPN-100, is under trials in the treatment of c | ||||
| 51905 | CPI-613(Devimistat ) | 95809-78-2 | ≧98.0% |  |
| CPI-613( Devimistat ) is an E1 pyruvate dehydrogenase (PDH) modulator that prevents c | ||||
| 16122906 | Brivaracetam | 357336-20-0 | 98% |  |
| Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a ra | ||||
| 18382 | eCF506 ( NXP 900 ) | 1914078-41-3 | ≧98.0% |  |
| eCF506 targets a molecule called Src tyrosine kinase that is required for breast canc | ||||
| 233901 | RRX-001 | 925206-65-1 | ≧98.0% |  |
| RRx-001 is a highly selective NLRP3 inhibitor with vascular normalization and tumor a | ||||
| 20460 | Ro5-3335 | 30195-30-3 | ≧98.0% |  |
| Ro5-3335 is a lipophilic small molecule RUNX1 inhibitor. | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| 122622 | CNS004 | 695205-24-4 | ≧98.0% |  |
| CNS004 is a novel compound that potentiates NMDA receptor currents based on glutamate | ||||
| 20278 | PD-159206 | 171744-42-6 | ≧94.0% |  |
| PD-159206 is a nucleocapsid inhibitor. It exhibits good antiviral activity against HI | ||||
| 171553 | Anle138b | 882697-00-9 | ≧98.0% |  |
| Anle138b is an oral, brain-penetrant, general inhibitor of protein aggregation. It wa | ||||
| 2320201 | Ro 24-7429 | 139339-45-0 | ≧98.0% |  |
| Ro24-7429 is a potent and orally activeHIV-1transactivator proteinTatantagonist. Ro24 | ||||